The effect of tightened compulsory admission laws on length of stay in emergency department for suicide attempters
Abstract
BACKGROUND: Suicide remains a major public health concern in South Korea. The emergency department (ED) is key in initial care for suicide attempters. In May 2017, South Korea implemented the Mental Health Welfare Act (MHWA), which strengthened procedural requirements for compulsory psychiatric admission. These changes may have affected admission processes and ED length of stay (LOS). This study evaluated the association between implementation of the MHWA and ED LOS for suicide attempters. METHODS: We conducted a retrospective observational study using the National Emergency Department Information System (NEDIS) database from 2016 to 2019. Patients aged ≥ 20 years who presented to level I or II emergency medical centers with intentional self-harm (ICD-10 codes X60–X84) and were admitted or transferred were included. To account for both the Mental Health Welfare Act (MHWA; May 30, 2017) and a subsequent Emergency Medical Services Act (EMSA) amendment (December 3, 2017), the study period was divided into three phases. Median ED LOS was compared using the Kruskal–Wallis test with Dunn’s post hoc analysis, and Cox proportional hazards regression was performed adjusting for age and sex. RESULTS: A total of 45,124 suicide attempters were analyzed. The median ED LOS for patients admitted to psychiatric departments was 7.4 h before the MHWA and 7.8 h after its implementation (P = 0.79). A statistically significant increase in ED LOS was observed in the period after both the MHWA and…
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.